naringenin has been researched along with Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Moneim, AM; Alfwuaires, M; Alzahrani, AM; Elsawy, H; Khalil, M | 1 |
| Canacankatan, N; Coskun Yilmaz, B; Guzel, S; Kibar, D; Uckun, Z; Yalaza, C | 1 |
| Afrin, R; Arumugam, S; Harima, M; Karuppagounder, V; Nakamura, M; Pitchaimani, V; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Ueno, K; Watanabe, K | 1 |
| Huang, XR; Lan, HY; Li, J; Meng, XM; Ren, GL; Zhang, Y | 1 |
| Prabu, SM; Renugadevi, J | 1 |
| Abdel-Maksoud, S; Ahmed, WA; Badary, OA; Owieda, GH | 1 |
6 other study(ies) available for naringenin and Kidney Diseases
| Article | Year |
|---|---|
Nephroprotective effect of naringin in methotrexate induced renal toxicity in male rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Caspase 3; Disease Models, Animal; Flavanones; Inflammation Mediators; Interleukin-6; Kidney; Kidney Diseases; Male; Methotrexate; Oxidative Stress; Rats; Tumor Necrosis Factor-alpha | 2021 |
Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Apoptosis; Dose-Response Relationship, Drug; Flavanones; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Vancomycin | 2020 |
Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; Endoplasmic Reticulum Stress; Fibrosis; Flavanones; Inflammation; Injections, Intravenous; Kidney Diseases; Male; MAP Kinase Signaling System; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Agents; Transcription Factor RelA | 2015 |
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.
Topics: Animals; Blotting, Western; Drug Therapy, Combination; Estrogen Antagonists; Fibrosis; Flavanones; Gene Expression Regulation; Immunoenzyme Techniques; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Pentacyclic Triterpenes; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta | 2015 |
Naringenin protects against cadmium-induced oxidative renal dysfunction in rats.
Topics: Animals; Antioxidants; Cadmium Chloride; Creatinine; Flavanones; Glutathione; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Oxidative Stress; Protein Carbonylation; Rats; Rats, Wistar; Urea; Uric Acid | 2009 |
Naringenin attenuates cisplatin nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Cisplatin; Flavanones; Kidney; Kidney Diseases; Kidney Function Tests; Male; Platinum; Rats; Urea | 2005 |